US FDA approves updated COVID shots for all people 65 and older and those at high risk
The U.S. Food and Drug Administration has approved updated COVID-19 vaccines for all people aged 65 and older and for people under 65 with higher health risks, the U.S. health secretary said on Wednesday.
The U.S. Department of Health and Human Services did not immediately respond to a Reuters request for comment. The three approved shots are made by Pfizer (PFE.N), opens new tab with German partner BioNTech (22UAy.DE), opens new tab, Moderna (MRNA.O), opens new tab, and Novavax (NVAX.O), opens new tab.
Pfizer said the emergency use authorization for its COVID vaccine for children under age 5 had been rescinded.
Moderna’s shot was approved for ages 6 months and up, Health Secretary Robert F. Kennedy Jr. said. Moderna was not immediately available for comment.
Pfizer and BioNTech’s updated version of Comirnaty was approved for everyone 65 and over, as well as in individuals ages 5 through 64 years with at least one underlying condition that puts them at high risk for severe outcomes from COVID infection, the company said in a press release.
